Understanding financial challenges faced by rural patients with Chronic Myeloid Leukemia

Who could benefit from this research

What this research studies

This research investigates the financial hardships experienced by individuals with Chronic Myeloid Leukemia (CML) living in rural areas of the Southeast. It aims to understand how these financial challenges impact their health outcomes, quality of life, and adherence to treatment. The study will gather insights from both patients and healthcare providers to identify the unique factors contributing to financial hardship in this population. By focusing on the experiences of rural CML patients, the research seeks to inform targeted interventions that can alleviate these financial burdens.

Why it matters

Where this research is happening

• Emory University
  Atlanta, United States Active

Researchers

• Principal investigator: Wright, Stephanie Lee — Emory University
• Study coordinator: Wright, Stephanie Lee

Related research

Other NIH-funded projects on the same topics.

• Chronic myeloid leukemia: how T cells and leukemia stem cells interact during treatment

  This NIH grant explores how immune cells and stubborn leukemia stem cells interact during therapy to better predict if patients can stay off treatment.

  NIH research Northwestern University · Chicago, United States · NIH-11418370

• Targeting DYRK2 to kill leukemia stem cells in CML

  Aims to find ways to remove leukemia stem cells in chronic myeloid leukemia by boosting a protein (DYRK2) that can halt their growth.

  NIH research Baylor College of Medicine · Houston, United States · NIH-11323889

• Why chronic myeloid leukemia sometimes resists treatment and how to improve TKI care

  This project looks at why some people with chronic myeloid leukemia respond differently to tyrosine kinase inhibitor drugs and aims to help more patients get deeper, longer-lasting remissions.

  NIH research University of California-Irvine · Irvine, United States · NIH-11306059

• Targeting a specific protein to eliminate leukemia stem cells in chronic myeloid leukemia.

  This study is looking at a new way to help people with chronic myeloid leukemia (CML) by focusing on a protein called DYRK2, which could help make leukemia stem cells less likely to survive, so patients might be able to stop their current treatments without their cancer coming back.

  NIH research Baylor College of Medicine · Houston, United States · NIH-11109689

• Understanding how some patients with chronic myeloid leukemia can remain healthy without treatment

  This study is looking into why some people with chronic myeloid leukemia can stay healthy without taking their medication, using mice to find out what helps them maintain remission, which could lead to better ways to manage the condition and lessen the need for long-term treatment.

  NIH research University of California-Irvine · Irvine, United States · NIH-11078332

• Improving treatment for chronic myeloid leukemia with targeted therapies

  This study is looking for ways to help people with chronic myeloid leukemia (CML) respond better to their main treatment, tyrosine kinase inhibitors (TKIs), especially during the first year after they are diagnosed, so that more patients can achieve a lasting remission and possibly a cure.

  NIH research University of California-Irvine · Irvine, United States · NIH-11016818

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.